Aug 18 2010
Glacoma Research Focuses on Anticardiolipins and IOP
A recent Canadian study on the progression of glaucoma shows that age and abnormal anticardiolipin antibody levels are key factors in the decrease of sufferers’ field of vision. Anticardiolipin antibodies are associated with such diseases as lupus, syphilis, and antiphospholipid syndrome, but the presence of these antibodies does not necessarily indicate that a patient has any of these conditions. According to study authors, “While this finding (regarding anticardiolipin antibodies [ACA]) is significant, its practical implications are unclear as only 5.5% of the tested patients had abnormal ACA levels.”
Researchers also looked at changes in intraocular pressure (IOP) and determined that a modest IOP reduction in patients with progressing glaucoma significantly reduced the rate of visual field decline.
Source: http://www.medscape.com/viewarticle/727024
Learn more about glaucoma risk factors on our website.
Comments Off
